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CD47 (integrin-associated protein), a multi-spanning transmembrane protein expressed in all cells
including red blood cells (RBCs) and leukocytes, interacts with signal regulatory protein α (SIRPα) on
macrophages and thereby inhibits phagocytosis of RBCs. Recently, we generated a novel C57BL/6J CD47
knockout (CD47−/− hereafter) mouse line by employing a CRISPR/Cas9 system at Center for Mouse Models
of Human Disease, and here report their hematological phenotypes. On monitoring their birth and
development, CD47−/− mice were born viable with a natural male-to-female sex ratio and normally
developed from birth through puberty to adulthood without noticeable changes in growth, food/water
intake compared to their age and sex-matched wild-type littermates up to 26 weeks. Hematological
analysis revealed a mild but significant reduction of RBC counts and hemoglobin in 16 week-old male
CD47
−/− mice which were aggravated at the age of 26 weeks with increased reticulocyte counts and mean
corpuscular volume (MCV), suggesting hemolytic anemia. Interestingly, anemia in female CD47−/− mice
became evident at 26 weeks, but splenomegaly was identified in both genders of CD47−/− mice from the
age of 16 weeks, consistent with development of hemolytic anemia. Additionally, helper and cytotoxic T
cell populations were considerably reduced in the spleen, but not in thymus, of CD47−/− mice, suggesting
a crucial role of CD47 in proliferation of T cells. Collectively, these findings indicate that our CD47−/− mice
have progressive hemolytic anemia and splenic depletion of mature T cell populations and therefore may
be useful as an in vivo model to study the function of CD47.
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Immune system recognizes self and non-self using
surface markers. CD47, also known as Integrin-Associated
Protein (IAP), is a glycoprotein which ubiquitously
exists on the surface of various cells including red blood
cells (RBCs). CD47 functions as a “marker of self” on
RBCs which prevents macrophages from phagocytosing
self RBCs [1-4]. Also, it is a potential immunoregulatory
molecule in integrin signaling as demonstrated in
downregulation of T cell activation and IL-12 production
by inactivating CD47 using thrombospondin-1 (TSP-1)
or anti-CD47 monoclonal antibodies [5-8]. In addition,
loss of CD47 in mice impaired resistance to E. coli
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injection by causing delay of polymorphonuclear
leukocyte migration to the site of infection, indicating its
role in cell migration [3]. Due to its role in immune
response, CD47 has been frequently knocked out with
other immunity related genes such as Recombination
Activating Gene-2 (Rag-2) and γc to create immune
deficient animal models for transplantation studies [9,
10].
Generally, senescent RBCs are destroyed by splenic
macrophages when they reach approximately 40-day-old
[11]. However, destruction of RBCs in an early stage
may occur in several conditions such as autoimmune
disorders, genetic defects, drugs and red blood cell
membrane instability, resulting in anemia. There are
several types of anemia such as iron deficiency anemia,
thalassemia, aplastic anemia, hemolytic anemia, sickle
cell anemia and pernicious anemia. Among these, lack of
CD47 expression in non-obese diabetic (NOD) mice has
been associated with severe autoimmune hemolytic
anemia, suggesting a crucial role of CD47 in maintaining
the physiological levels of RBCs [12].
In this study, we report a novel CD47 knockout (KO)
mouse model (C57BL/6J-CD47em1hwl/Korl, CD47−/−
mice hereafter) that we generated using a CRISPR/Cas9
system at Center for Mouse Models of Human Disease
(CMHD), and their hematological phenotypes. We found
hemolytic anemia in 16-week-old CD47−/− mice, which
was aggravated in 26 weeks. In addition, our CD47−/−
mice had a defective immune system due to reduction of
mature T cell populations in the spleen. These findings
confirm the role of CD47 in blood cells, indicating that
our CD47−/− mice may serve as a reliable platform to
study the function of CD47.
Materials and Methods
Generation of CD47−/− mice and measurement of
major physiological parameters
CD47−/− mice were generated in the C57BL/6J
background using a CRISPR/Cas9 system as previously
described [13]. For this study, heterozygous breeding
pairs were used to produce CD47−/− mice and their
wildtype (WT) littermates (n=7-9 per group). Ear tissues
were used for genotyping in a conventional PCR with
specific primers; forward; 5'-GGT CGG TCG TTT CCC
TTG AA-3' and reverse; 5'-GAT CCC CGA GCC ACT
CAC-3'. Mice were housed in an AAALAC International
accredited specific pathogen free (SPF) facility (#001169)
at Seoul National University Hospital under standard
housing conditions 12 h dark/light cycle, 40-60%
relative humidity and 22±2oC with free access to food
(LabDiet 5002 Certified Rodent Diet, PMI Nutrition
International, USA) and water. All experiments were
approved by the Institutional Animal Care and Use
Committee in Seoul National University Hospital and
animals were maintained in accordance with the Guide
for the Care and Use of Laboratory Animals [14].
From 4 weeks after birth to 26 weeks, body weight and
food/water intake of mice were measured once a week
with daily observation of clinical signs. Measurement of
food and water intake was carried out in the day cycle
and calculated as the amount consumed per mouse
during 24 hours.
Hematology, serum biochemistry and urinalysis
Hematology, serum biochemistry and urinalysis were
carried out as described [15]. Briefly, at the age of 16 and
26 weeks, all mice were deeply anesthetized with
isoflurane and peripheral blood was collected from the
abdominal vein in a K
2
EDTA contained tube (BD
Microtainer, USA) for hematologic analysis using an
ADVIA 2021i (Siemens Healthcare, USA). Serum
biochemistry and urinalysis were carried out using a
Hitachi 7070 (Hitachi, Tokyo, Japan) and a CLINTEK
Adventus analyzer (Siemens Healthcare), respectively.
Histopathology
At necropsy, gross examination was performed for all
organs. Then, major organs, except for eyes, testis and
epididymis which were fixed in Davidson solution and
Bouin’s solution, respectively, were fixed in 10% neutral
buffered formalin and embedded in paraffin wax after
dehydration and clearing process. After sectioning in a
thickness of 4-6μm, tissues were stained with hematoxylin
and eosin. To examine the levels of intracellular
accumulation of iron in the spleens, we stained the tissue
using Prussian blue reaction. Breifly, the paraffin-
embedded spleen was sectioned and re-hydrated after
deparaffinization. The tissue section was stained in
freshly prepared 5% potassium ferrocyanide (Sigma
Aldrich) in 10% HCl for 20 min and then counterstained
with neutral red (Sigma Aldrich) for 5 minutes. All
stained tissues were observed under a microscope
(BX61, Olympus).
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Flow cytometry
Cells were isolated from the spleens, bone marrow and
thymuses of 16-week-age WT and CD47−/− mice (male;
n=3 and female; n=3 per genotype) and stained with
antibodies for flow cytometric analysis as described
[15]. In this study, we used V450-anti-CD3e (500A2),
FITC-anti-CD4 (RM4-5), APC-anti-CD5 (53-7.3),
BV605-anti-CD8a (53-6.7), Alexa700-anti-CD19 (1D3),
and PerCP-anti-CD45R (RA3-6B2) to label distinct
lymphocyte populations. All antibodies employed in this
study were from BD Bioscience and used at 1:200
except anti-CD4 antibody (1:500). After staining and
washing, 20,000 cells were analyzed using a FACS
Calibur (BD).
Statistics
All data were expressed as mean±SD, and statistical
analysis was performed using a two-tailed t test in a
SPSS software (version 22.0). P<0.05 was considered to
be statistically significant.
Results and Discussion
Normal development of CD47−/− mice
To evaluate the role of CD47, we generated a novel
CD47−/− mouse line by introducing a double-strand DNA
break of CD47 exon 1 using a CRISPR/Cas9 system and
inducing non-homologous end joining repair, which
resulted in a deletion of 26 base pairs which created a
frameshift mutation and a premature stop codon (Figure
1A).
To characterize the phenotype of CD47−/− mice, we
first examined their development with monitoring of
main physiological parameters including sex ratio,
genotype, body weight gain, food and water intake for
26 weeks. At birth, there were no changes in the sex ratio
of littermates (male; n=45, female; n=43 out of 88
siblings; CD47−/− male; n=13, CD47−/− female; n=12 out
of 25 CD47−/−mice), and the ratio of genotypes of mice
born from CD47+/- parents was 1:1.6:0.8 for WT,
CD47+/- and CD47−/−, indicating a Mendelian inheritance
Figure 1. CRISPR/Cas9-mediated gene-targeting strategy to generate CD47−/− mice. (A) A schematic drawing shows the
sequence of the CD47 alleles in the wild-type (WT) and CD47−/− (KO) location of the start codon (green), RNA-guided engineered
nucleases (RGEN) target sequence (blue) and protospacer adjacent motif (PAM; red). The double-strand break induced by the
CRISPR/Cas9 was repaired by non-homologous end joining, resulting in a frameshift mutation by deleting 26 nucleotides and
thereby creation of a premature termination codon (asterisk mark). (B) PCR products amplified from the targeted region of genomic
DNA revealed genotypes of mice. 
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pattern of the knockout alleles with no embryonic
lethality. For 26 weeks, body weight gain and food/water
consumption of CD47−/− mice was comparable to WT
(Figure 2), suggesting that loss of the CD47 gene did not
affect the postnatal development.
Progressive anemia in CD47−/− mice
When peripheral blood was collected from 16-week-
old mice and analyzed, male CD47−/− mice showed a
significant reduction of RBC counts (11.4 %, P<0.01)
and hemoglobin (10.1%, P<0.01) at the age of 16 weeks,
while no abnormality was observed in the blood of
female CD47−/− mice (Figure 3A). The anemia-like
feature observed in male CD47−/− mice became more
evident at 26weeks with increase of reticulocytes
(136.2%, P<0.01) and MCV (102.5%, P<0.05) in
Figure 2. Body weight change, food and water consumption of CD47−/− mice. (A) The body weight, (B) daily food intake and (C)
water consumption of wildtype (WT) and CD47−/− mice were measured weekly for 26 weeks. No significant change was observed in
any of the parameters between WT male (open squares) and CD47−/− male (filled squares), and between WT female (open circles)
and CD47−/− female (filled circles) mice.
Figure 3. Hematological analysis of peripheral blood from CD47−/− mice. (A) 16 week-old of WT and CD47−/− mice (n=3 per group).
Significant decrease of RBC counts and hemoglobin was observed in CD47−/− males compared to their wild-type counterparts
(black bars for WT and dark gray bars for CD47−/− mice). (B) In the blood from 26 week-old of WT and CD47−/− mice (n=7 per
group), RBC counts, hemoglobin and hematocrit were significantly declined in both male and female (light gray bars for WT and
white bars for CD47−/− mice), while reticulocyte counts in both genders and mean corpuscular mean volume (MCV) only in male
were increased. *P<0.05 and **P<0.01.
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addition to the reduction of RBC counts (13.1%,
P<0.01), hemoglobin (10.9%, P<0.01) and hematocrit
(10.7%, P<0.01) as shown in Figure 3B. 26-week-old
female CD47−/− mice also showed similar changes in the
parameters for erythrocytes; reduction of RBC counts
(8.0%, P<0.05), hemoglobin (11.1%, P<0.01) and
hematocrit (7.5%, P<0.05) with increased reticulocytes
(116.0%, P<0.05). These findings indicate the development
of anemia in our CD47−/− mice, which is progressively
aggravated over aging.
Serum biochemistry (Table 1) and urinalysis (data not
shown) showed no changes between CD47−/− mice and
their WT littermates, suggesting that lack of CD47 may
not affect the function of other organs, especially liver
and kidney.
Splenomegaly with intracellular iron accumulation in
CD47
−/− mice
Based on the function of CD47 in RBCs, anemia
observed in our CD47−/− mice was possibly caused by
Table 1. Serum biochemistry of CD47−/− mice
Parameters
WT male
(n=7)
CD47
−/− male
(n=7)
WT female
(n=9)
CD47
−/− female
(n=8)
BUN (mg/dL) 23.3±9.50 22.9±3.40 18.6±2.90 22.8±4.90
Chol (mg/dL) 112.7±23.40 119.9±8.400 86.1±16.8 81.9±15.0
T.protein (g/dL) 4.5±0.4 4.4±0.4 4.5±0.3 4.6±0.3
Albumin (g/dL) 1.6±0.1 1.7±0.1 1.7±0.1 1.7±0.1
T.bil (mg/dL) 0.05±0.02 0.06±0.04 0.08±0.04 0.04±0.04
ALP (IU/L) 194.2±48.10 211.4±32.60 288.3±70.40 310.3±53.30
AST (IU/L) 83.7±64.1 111.7±104.5 110.1±95.00 113.5±34.60
ALT (IU/L) 32.8±15.7 42.1±31.6 51.1±58.2 44.6±16.1
γGT (IU/L) -0.5±1.2- -0.6±0.8- 0.2±0.7 -0.3±0.9-
Creatinine (mg/dL) 0.28±0.03 0.29±0.06 0.25±0.12 0.28±0.10
TG (mg/dL) 52.0±25.3 51.7±24.5 23.6±6.40 37.6±25.9
Glu (mg/dL) 251.0±43.50 262.4±17.90 275.8±38.30 264.6±38.90
*Abbreviation. Blood urea nitrogen (BUN), cholesterol (Chol), total protein (T.protein), total bilirubin (T.bil), alkaline phosphatase (ALP),
aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma (γ)-glutamyl transferase (γGT), triglyceride (TG), glucose
(Glu).
Figure 4. Increased size and weight of spleens in CD47−/− mice. Representative images and bar graphs show increased size and
weight of spleens in the 16 week-old (A) and 26 week-old (B) CD47−/− mice compared to their respective wild-type littermates. The
graphs are expressed as a percentage of organ weight/body weight (black bars, WT male; dark gray bars, CD47−/− male; light gray
bars, WT female; and white bars, CD47−/− female mice). Scale bar; 5 mm. *P<0.05 and ***P<0.001.
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increased hemolysis. As spleen is commonly enlarged in
hemolytic anemia due to accumulation of RBCs and
macrophages [16,17], we examined the organs of CD47−/−
mice with a particular focus on their spleens. While no
changes were found in other organs of CD47−/− mice,
spleens of CD47−/− mice were found to be significantly
larger than those of WT littermates (Figure 4, Table 2).
When the organ per body weight ratio was calculated,
both genders of 16-week-old CD47−/− mice exhibited
enlarged spleens (Figure 4A; 169.3% increase compared
to WT male, 139.0 % for female mice, P<0.05 for both).
In line with the progression of anemia observed in
hematological analysis, splenomegaly was consistently
observed in both genders of 26 week-old CD47−/− mice
(Figure 4B; 143.5 % increase in male, P<0.05 and 161.8
% in female, P<0.001). Except for the spleen, no other
organs in CD47−/− mice showed notable changes (Table
2).
When the spleen was histopathologically examined,
cells containing brown-gold pigments were more frequently
observed in CD47−/− mice compared to WT mice
(Figures 5A, 5B). As loss of CD47 was previously
associated with increased destruction of RBCs by
macrophages, these pigments were likely hemosiderins
derived from increased degradation of iron-containing
hemoglobins in RBCs and therefore we visualized
intracellular iron in the tissue using Prussian blue
reaction to determine the identity of the pigments.
Staining of iron revealed noticeable increase in the
number of dark blue-stained cells with a tendency of
higher intracellular staining levels in CD47−/− mice than
WT mice (Figures 5C, 5D), indicating the increased
intracellular accumulation of hemosiderns. It is tempting
to postulate that these hemosiderin-containing cells were
macrophages due to their function in hemolysis, but this
proposition may need to be confirmed. There are several
types of anemia reported in humans. Among them, the
anemia identified in our CD47-−/− mice is likely hemolytic
based on the following observations; CD47−/− mice
showed concurrent reduction of RBC counts, hemoglobins
and hematocrit with increased reticulocytes, indicating
loss of mature RBCs with increased release of immature
RBCs into the blood as a compensatory response.
Although the anemic feature was not evident in 16-
Table 2. Absolute and relative weight of major organs of 26-week-old CD47−/− mice
Organ
WT male
(n=7)
CD47
−/− male
(n=7)
WT female
(n=9)
CD47
−/− female
(n=8)
Body weight (g) 38.03±4.560 35.03±3.940 24.67±3.110 23.29±2.750
Liver (g) 1.71±0.25 1.69±0.28 1.04±0.18 1.04±0.14
　
(g%) 4.53±0.62 4.79±0.31 4.19±0.24 4.46±0.29
Spleen (g) 0.09±0.01 00.11±0.02* 0.08±0.01 000.13±0.02***
　
(g%) 0.23±0.05 00.33±0.08* 0.34±0.02 000.55±0.08***
Kidney (right) (g) 0.20±0.03 0.18±0.03 0.13±0.01 0.12±0.01
　
(g%) 0.53±0.08 0.52±0.06 0.54±0.05 0.52±0.05
Kidney (left) (g) 0.20±0.03 0.18±0.02 0.13±0.02 0.12±0.01
　
(g%) 0.54±0.12 0.52±0.05 0.52±0.04 0.51±0.05
Adrenal gland (g) 0.0013±0.0006 0.0014±0.0040 0.0032±0.0009 0.0027±0.0006
 (right) (g%) 0.0033±0.0014 0.0040±0.0014 0.0130±0.0027 0.0117±0.0022
Adrenal gland (g) 0.0012±0.0004 0.0015±0.0005 0.0033±0.0008 0.0035±0.0010
(left) (g%) 0.0031±0.0010 0.0045±0.0017 0.0132±0.0029 0.0151±0.0039
Testis (right) (g) 0.12±0.02 0.11±0.01 0.0045±0.0008 0.0030±0.0010
/ovary (right) (g%) 0.32±0.05 0.32±0.03 0.0187±0.0047 0.0132±0.0044
Testis (left) (g) 0.11±0.01 0.11±0.01 0.0037±0.0012 0.0028±0.0009
/ovary (left) (g%) 0.30±0.05 0.32±0.02 0.0150±0.0048 0.0122±0.0041
Thymus (g) 0.05±0.01 0.04±0.01 0.05±0.01 0.04±0.01
　
(g%) 0.13±0.01 0.11±0.01 0.19±0.02 0.19±0.03
Heart (g) 0.15±0.02 0.15±0.02 0.12±0.01 0.12±0.02
　
(g%) 0.40±0.05 0.44±0.06 0.50±0.04 0.50±0.07
Lung (g) 0.15±0.01 0.15±0.01 0.14±0.01 0.14±0.01
　
(g%) 0.40±0.06 0.43±0.06 0.58±0.06 0.60±0.10
Brain (g) 0.46±0.03 0.46±0.02 0.47±0.01 0.48±0.01
　
(g%) 1.23±0.16 1.33±0.13 1.93±0.23 2.08±0.25
*P<0.05 and ***P<0.001 in comparison to respective gender-matching WT mice
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week-old female mice, both genders of CD47−/− mice
had enlargement of the spleen which continued to the
age of 26 weeks with concurrent aggravation of
hematological parameters regarding RBCs. Furthermore,
the elevated destruction of RBCs was demonstrated by
the increased number of hemosiderin-loaded cells with
higher amount of hemosiderins accumulated in each
cells of the CD47−/− spleens, strongly supporting our
hypothesis. Despite these findings, our data however do
not exclude the possibility of other types of anemia with
similar features. Therefore, further investigation is
warranted to characterize the type and clinical manifestation
of the anemia in our CD47−/− mice.
The findings on the development of hemolytic anemia
in our CD47−/− mice have not been reported in the
previously generated CD47−/− mice [4], but were closely
in line with AIHA in CD47−/− NOD mice [12] with
several different features noted; CD47−/− NOD mice
showed much greater reduction of hematocrit than our
CD47−/− mice, while jaundice was only observed in
CD47−/− NOD mice, suggesting a mild degree of
hemolytic anemia in our mice. The mouse strains used
in generating models (NOD vs. C57Bl/6) may have
played a role in causing these discrepancies in manifestation
of hemolytic anemia between the two mouse lines.
Reduction of T cells in the spleen of CD47−/− mice
Next, we examined changes in subpopulations of
Figure 5. Intracellular accumulation of iron-containing hemosiderin in the splenic cells of 26-week-old CD47−/− mice. Representative
images of H&E stained spleen tissues from WT (A and C) and CD47−/− mice (B and D) show brown-gold pigmented cells
(arrowheads). The pigmented cells were more frequently observed in CD47−/− compared to WT mice. Prussian blue staining (E and
F) revealed that there were more iron-accumulated cells (arrows) in the spleens of CD47−/− mice than WT. Scale bars for the
images with low magnification (x10) and high magnification (x60) are 250 and 2 μm, respectively.
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lymphocytes including T and B cells in CD47−/− mice as
inactivation of CD47 previously resulted in reduction of
T cell populations in the spleen [18]. To assess the
impact of CD47 deficiency on those lymphocytes, we
performed flow cytometry on the cells isolated from 16-
week-old mice spleens, thymuses and bone marrow.
Flow cytometry analysis on splenic lymphocytes revealed
a remarkable reduction of CD3+CD5+, CD3+CD4+ and
CD3+CD8+ T cells (Figures 6A, 6C, P<0.01 for all),
while no change was found in CD19+B220+ B cell
population. The number of CD19+B220+ B cells from
the bone marrow of CD47−/− mice was also comparable
to WT (Figures 6B, 6D). Our findings recapitulated the
crucial role of CD47-SIRPα interaction on T cell
proliferation as similar findings on the reduction of
CD4+ T cells have been reported in the spleen of the
CD47 binding partner SIRPα-deficient mice [18].
Contrary to the reduction of T cells in the spleen, no
change was detected in thymic T cell populations when
compared to WT (Figures 6C, 6F), suggesting differential
roles of CD47 in T cells depending on their developmental
stage; CD47 functions in the proliferation of T cells
which occurs in the spleen, but not at the stage of initial
development through negative selection in the thymus
[19].
In this study, we generated a novel CD47−/− C57BL/6J
Figure 6. Flow cytometric analysis of cells isolated from the spleens, thymuses and bone marrow of CD47−/− mice. (A and D) Dot
plots display CD3+CD5+, CD3+CD4+ and CD3+CD8+ T cell populations as well as CD19+B220+ B cell population in the spleen. All
the T cell populations detected here were significantly decreased in CD47−/− mice compared to WT. (B and E) Cells from the bone
marrow show no changes in CD19+B220+ B cells between WT and CD47−/− mice. (C and F) The numbers of CD3+CD8+ T cells
isolated from thymuses are comparable between WT and CD47−/− mice. **P<0.01, NS: Not significant.
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mouse line using a CRISPR/Cas9 system and found a
progressive hemolytic anemia as well as profound
reduction of mature T cell populations in the spleen.
Intriguingly, despite its ubiquitous expression, loss of
CD47 mainly resulted in hematological phenotypes
without causing embryonic lethality, developmental
defects or any noticeable changes in the structure and
function of other tissues, indicating its preferred function
in blood cells. These results, however, do not exclude the
possible role of CD47 in other types of cells and further
investigation may be required to reveal cell-specific
impact of CD47 deficiency. In conclusion, CRISPR/
Cas9-mediated generation of CD47−/− mice confirmed
the function of CD47 in the maintenance of RBC and T
cell populations, demonstrating their usefulness as an in
vivo platform to study the function of CD47.
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